Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can custom therapy help stroke survivors with everyday tasks?

NCT ID NCT05829421

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a specially designed occupational therapy program could help people with mild-to-moderate thinking problems after a stroke perform daily activities like dressing or cooking. Only 8 people took part, and the goal was to see if the therapy was practical to deliver and study, not whether it actually works. The therapy was personalized based on each person's specific cognitive difficulties.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
individualized occupational therapy adapted to cognitive impairments
What this could lead to
If successful, this approach could help stroke survivors manage daily tasks more independently.
What could go wrong
This is a very small feasibility study with only 8 participants. It cannot prove the therapy works, only that it might be possible to test it in a larger trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

May 2023

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

PATIENTS: Inclusion criteria: * first-ever symptomatic stroke, * age ≥ 18 years, * residence in Frederiksberg Municipality, Denmark, * independent in pre-stroke everyday life (≤ 2 points on the modified Rankin Scale, mRS), * experiencing problems in performing ADLs due to cognitive impairment; these problems are expected to still be present at hospital discharge, * medical condition allows commencement of rehabilitation focused on ADL and cognition * fully aware or mild-to-moderate unawareness of deficits (≤ 2 points on the Bisiach Anosognosia Scale, BAS), * a global cognitive function corresponding to ≥ 17 points on the Montreal Cognitive Assessment, MoCA, * ≤ 10 points on the depression subscale of the Hospital Anxiety and Depression Scale, HADS, * able to provide informed consent, as evaluated by the recruiting healthcare professional(s), * logistically possible to perform baseline assessments and create an individualised intervention plan during hospital stay * provides informed consent Exclusion criteria: * psychiatric conditions causing difficulties or preventing participation, as evaluated by the recruiting health care professional(s) * communication problems causing difficulties or preventing participation, as evaluated by the recruiting healthcare professional(s) CAREGIVERS: Inclusion criteria: * appointed as close carer (by a patient who consented to participate), * age ≥18y, * provides informed consent. Exclusion criteria: -communication problems or other issues causing difficulties in participation as evaluated by the recruiting healthcare professional(s). Patients without a close carer will not be excluded. CLINICAL STAFF: Inclusion criteria: * appointed as local project managers, or OTs or NPs who conduct assessments or deliver the intervention in the participating centres, * provides informed consent. Exclusion criteria: \- unable to to follow a preliminary English version of the intervention manual.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive impairment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bispebjerg and Frederiksberg Hospital

    Copenhagen, 2400, Denmark

  • Neurorehabilitation Centre Østervang

    Frederiksberg, 2000, Denmark

  • the Day Rehabilitation Centre

    Frederiksberg, 2000, Denmark

  • the Inpatient Rehabilitation Centre

    Frederiksberg, 2000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.